Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ROQU Group was an Irish digital health and healthcare IT company best known for Health Passport Worldwide, a mobile-based platform created during the COVID-19 pandemic to link verified test and vaccination records with identity and access workflows. The company positioned the product for use across travel, events, workplaces, education, and other settings that needed rapid health-status verification rather than for development of therapeutics. ROQU partnered with testing and healthcare stakeholders to support COVID-19 screening programs and promoted the platform internationally in multiple countries. Available public evidence indicates the legal entity was incorporated in Ireland in 2020 and later entered liquidation, so it does not appear to be an active operating biotech or pharma company today.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ROQU Group.